𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modelling disease progression in terms of exposure history

✍ Scribed by Karen Bandeen-Roche; Charles B. Hall; Walter F. Stewart; Scott L. Zeger


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
229 KB
Volume
18
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis


We consider the relationship between accumulating exposure to a putative agent and the associated change in physiologic function. This type of problem is common to prospective studies of cognitive, pulmonary and cardiovascular function. A general model is proposed for data from prospective, observational studies with concurrent measures of exposures and continuous outcome measures. This model permits non-linearity in the relationship between exposure and outcome and is designed to describe outcome in terms of one's entire exposure history. As exposure data are often severely right-skewed, we use regression spline estimation methods which localize the in#uence of extreme points. We illustrate our methodology using data from a longitudinal epidemiologic investigation of the e!ects of amateur boxing on neuropsychologic function.


πŸ“œ SIMILAR VOLUMES


Mathematical Model of Progressive Renal
✍ Pawan Chaturvedi; Michael F. Insana πŸ“‚ Article πŸ“… 1997 πŸ› Elsevier Science 🌐 English βš– 215 KB

A simple mathematical model is proposed that predicts the dynamics of chronic progressive renal disease. The model consists of coupled linear differential equations formed from three state variables, four control parameters, and three parameters related to initial conditions. All have straightforwar

Natural history and disease progression
✍ Chee-Kin Hui; Nancy Leung; Siu-Tsan Yuen; Hai-Ying Zhang; Kar-Wai Leung; Lei Lu; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 156 KB

In view of the findings that high hepatitis B virus (HBV) deoxyribonucleic acid (DNA) is associated with increased risk of chronic hepatitis B (CHB)-related complications, disease progression in CHB patients in the immune-tolerant phase is uncertain. We evaluated disease progression in 57 immune-tol

Progression of liver fibrosis in women i
✍ Vincent Di Martino; Pascal Lebray; Robert P. Myers; Emmanuelle Pannier; ValΓ©rie πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 1 views

Female sex is a protective factor for the progression of fibrosis in patients with chronic hepatitis C virus (HCV) infection. Experimental data suggest that estrogens may have an antifibrotic effect. The objective of this study was to evaluate the influence of past pregnancies, oral contraceptives,

Progression of liver fibrosis in women i
✍ Mical Campbell; Yu-Xiao Yang; K. Rajender Reddy πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 1 views

We read with interest the paper by Di Martino et al. published in the December 2004 issue of HEPATOLOGY 1 that examines estrogen-related effects on hepatitis C fibrosis. Specifically, progression of hepatitis C fibrosis was correlated with prior pregnancies, menopausal status, past use of oral contr

Clinical measures of progression in Park
✍ Werner Poewe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Abstract Despite all recent advances in symptomatic therapy Parkinson's disease (PD) continues to be a relentlessly progressive neurodegenerative disorder. Therefore therapies that will slow or hold disease progression are a major medical unmet need in PD. Clinical measures of disease progressio